SMTL ID : 6c7q.1

BRD4 BD2 in complex with compound CE277

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.51 Å

Oligo State

monomer

Ligands

1 x EO1: 7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-2-methyl-N-(1-methyl-1H-indazol-3-yl)-9H-pyrimido[4,5-b]indol-4-amine(Non-covalent)

EO1.1: 11 residues within 4Å: Chain A: W.45, P.46, F.47, L.56, L.58, C.100, Y.103, N.104, H.108, V.110, M.113 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.45, A:W.45, A:P.46, A:P.46, A:F.47, A:L.56, A:L.56, A:L.58, A:Y.103, A:V.110, A:V.110 Hydrogen bonds: A:P.46, A:N.104 pi-Stacking: A:W.45

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhao, Y. et al., Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. J. Med. Chem. (2018)

Release Date

2018-08-01

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4

Related Entries With Identical Sequence